Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c- myc specific ribozyme

Jin Cheng,Jinyan Luo,Xueyong Zhang,Jialu Hu,Hongxiang Hui,Chengji Wang,Arnold Stern
DOI: https://doi.org/10.1038/sj.cgt.7700127
IF: 5.854
2000-01-01
Cancer Gene Therapy
Abstract:A ribozyme (RZ) gene targeting c- myc mRNA was synthesized and cloned. Cleavage reaction showed that cleavage of the RZ was efficient and specific. The RZ gene-containing retrovirus vector pDOR-RZ was transfected into HCC-9204 hepatoma cells, which constitutively express high levels of c- myc using Lipofectamine. Positively transfected cells were selected using G418. In situ hybridization showed that both pDOR-RZ and pDOR vectors had been integrated into the chromosome of HCC-9204 cells. Dot blot hybridization indicated that expression of the RZ was only evident in pDOR-RZ-transfected HCC-9204 cells. Avidin-biotin complex enzyme-linked immunosorbent assay showed that c- myc expression was down-regulated. Chromatin aggregation into compact masses, cytoplasmic vacuole degeneration, and blurring of cytoplasm structure were observed by transmission electron microscopy in HCC-9204-RZ cells. These results suggest that the use of a c- myc mRNA cleaving enzyme could be most effective in tumor cells that are highly proliferative and constitutively express high levels of c- myc .
What problem does this paper attempt to address?